Drug Shortage Report for DALACIN C PHOSPHATE
Report ID | 134278 |
Drug Identification Number | 00260436 |
Brand name | DALACIN C PHOSPHATE |
Common or Proper name | Dalacin C Phosphate |
Company Name | PFIZER CANADA ULC |
Market Status | DORMANT |
Active Ingredient(s) | CLINDAMYCIN |
Strength(s) | 150MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 25x2mL |
ATC code | J01FF |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-06-14 |
Estimated end date | 2023-04-30 |
Actual end date | 2023-04-26 |
Shortage status | Resolved |
Updated date | 2023-04-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v22 | 2023-04-27 | English | Compare |
v21 | 2023-04-26 | French | Compare |
v20 | 2023-04-26 | English | Compare |
v19 | 2023-03-16 | French | Compare |
v18 | 2023-03-16 | English | Compare |
v17 | 2021-12-10 | French | Compare |
v16 | 2021-12-10 | English | Compare |
v15 | 2021-06-15 | French | Compare |
v14 | 2021-06-15 | English | Compare |
v13 | 2021-06-02 | French | Compare |
v12 | 2021-06-02 | English | Compare |
v11 | 2021-05-06 | French | Compare |
v10 | 2021-05-06 | English | Compare |
v9 | 2021-03-17 | French | Compare |
v8 | 2021-03-17 | English | Compare |
v7 | 2021-03-02 | French | Compare |
v6 | 2021-03-02 | English | Compare |
v5 | 2021-02-27 | English | Compare |
v4 | 2021-02-25 | French | Compare |
v3 | 2021-02-25 | English | Compare |